Sample Data Plans

First Data Sample Plan

Applicants for programs that are not exempt from our Open Data policy requirements will complete a data plan as part of their application. They will be prompted to answer the following questions.

What data outputs will the research generate?

Please do not reference potential publication or presentation of your results. Our open data policy requires a plan for depositing data in an AHA-approved repository whether or not results are ever published or presented. Making data available with published results does not satisfy this policy requirement. (max 2048 chars) [Note: Open data plans cover a range of non-textual materials, including datasets, statistics, transcripts, and survey results, associated with these objects. The data is, in essence, the factual information that is necessary to replicate and verify research results. The data must be accompanied by proper documentation. This documentation, often referred to as metadata, is necessary to allow others to use the data properly and without confusion. Consistent with NIH guidelines, the metadata must provide "information about the methodology and procedures used to collect the data, details about codes, definitions of variables, variable field locations, frequencies, and the like. The precise content of documentation will vary by scientific area, study design, the type of data collected, and characteristics of the dataset."]

Sample Answer: Our research will generate mechanistic data on the regulation of the Sbf complex involved in autophagy and myocardial ischemia/reperfusion. Specifically, the data content will focus on Sbf/MTMR13 and PI3KC2 genotype and phenotype analysis in flies, human and rat cells and mice, with an emphasis on the cellular basis for the starvation-induced Sbf/MTMR13 interactions and modifications that promote Rab21 GTPase activity. Meta data will also be included in the selected repositories.

(A few sentences about the data and metadata that will be generated, clearly stating what will be deposited where, if multiple repositories are selected)

Approximate date of when the data will be shared?

2019-12-31

(Date selected must be as soon as possible, and no later than the time of an associated publication or the end of the award period)

Where will the data be made available?

Subject-focused repositories, when available, are preferred over general repositories. (Please select all applicable pre-approved repositories and/or select "other" to request consideration of an additional repository.)

Sample Repository Selections:

Intact

NCBI Gene

Please explain any limits to data sharing that might be required.

Examples include safeguarding research participants or gaining appropriate intellectual property protection. If you are not requesting permission to restrict access to some portion of your data then please leave this field blank.

[Note: The circumstances in which a grant recipient may receive permission to restrict access to data are narrow. A description of possible conditions is located on our website.](max 1000 chars)

If any limits to data sharing are required, they should be referenced in the response to this question.

Why this is a strong data plan

• Answer addresses all the data and metadata that would be needed to replicate and validate the research.
• Does not reference potential publications, presentations, or patents.
• Does not reference adhering to requirements of other organizations or the NIH. Our AHA policy may not be consistent with these other policies.
• Selected at least one AHA-Approved repository for depositing their data. The PI can select multiple subject-specific repositories and even included a general repository or a source code repository if needed to make sure all the data necessary to validate and replicate the research is freely and publicly available in an AHA-approved repository by the end of the award period..

Second Sample Data Plan

What data outputs will the research generate?

Please do not reference potential publication or presentation of your results. Our open data policy requires a plan for depositing data in an AHA-approved repository whether or not results are ever published or presented. Making data available with published results does not satisfy this policy requirement. (max 2048 chars)

[Note: Open data plans cover a range of non-textual materials, including datasets, statistics, transcripts, and survey results, associated with these objects. The data is, in essence, the factual information that is necessary to replicate and verify research results. The data must be accompanied by proper documentation. This documentation, often referred to as metadata, is necessary to allow others to use the data properly and without confusion. Consistent with NIH guidelines, the metadata must provide "information about the methodology and procedures used to collect the data, details about codes, definitions of variables, variable field locations, frequencies, and the like. The precise content of documentation will vary by scientific area, study design, the type of data collected, and characteristics of the dataset."]

Sample Answer: The existing genomic and phenotypic data from the Framingham Heart Study and the Atherosclerosis Risk in Communities Study that will be used in this study are already available in dbGaP. These data are made available with metadata. All additional data generated in the project, i.e. the additional Illumina 450K BeadChip DNA methylation data on FHS and ARIC participants selected on the basis of smoking history, will also be posted on DBGAP with accompanying metadata.

Approximate date of when the data will be shared?

2017-7-31

(Date selected must be as soon as possible, and no later than the time of an associated publication or the end of the award period)

Where will the data be made available?

Subject-focused repositories, when available, are preferred over general repositories.

(Please select all applicable pre-approved repositories and/or select "other" to request consideration of an additional repository.)

Sample Repository Selection:

Database of Genotypes and Phenotypes (dbGaP)

Please explain any limits to data sharing that might be required.

Examples include safeguarding research participants or gaining appropriate intellectual property protection. If you are not requesting permission to restrict access to some portion of your data then please leave this field blank.

[Note: The circumstances in which a grant recipient may receive permission to restrict access to data are narrow. A description of possible conditions is located on our website.](max 1000 chars)

Sample Answer:

We protect participant confidentiality by exchanging data in protected formats, with all HIPPA and other identifiers removed. Therefore, if necessary we will restrict the sharing of any information that would reveal the identification of the participants.